| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
( Bristol Laboratories Inc., Syracuse, New York)
A procedure was described for assaying potential antitumor agents by an agar diffusion method. The technic employed a substrain of the S-3 clonal strain of HeLa selected for ability to grow well under agar. Activity was manifested by a zone of growth inhibition as a direct function of dose.
* These studies were supported in part by funds supplied under contract SA-43-ph-1908 with the Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health.
Received 11/30/59.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |